Published:
The Medicines Company to Participate in the 27th Annual JP Morgan Healthcare Conference
The Medicines Company (NASDAQ: MDCO) is
scheduled to participate in the 27th Annual JP Morgan Healthcare Conference
on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A
company overview and outlook will be provided in the presentation.
The session will be webcast with a link available at The Medicines
Company's website: http://www.themedicinescompany.com.
MDCO-G
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment
of critical care patients through the delivery of innovative,
cost-effective medicines to the worldwide hospital marketplace. The Company
markets Angiomax® (bivalirudin) in the United States and other countries
for use in patients undergoing coronary angioplasty, and Cleviprex®
(clevidipine butyrate) injectable emulsion in the United States for the
reduction of blood pressure when oral therapy is not feasible or not
desirable. The Company also has an investigational antiplatelet agent,
cangrelor, in late-stage development and a serine protease inhibitor,
CU-2010, in early-stage development. The Company's website is
www.themedicinescompany.com.
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,Pharmaceuticals and Biotech:Drugs, PharmaceuticalsandBiotech:Biotech, ,NASDAQ01,NASDAQ01,NASDAQ01,NJ,PARSIPPANY, NJ
Search News
Daily News
